Page last updated: 2024-08-25

perindoprilat and Head and Neck Neoplasms

perindoprilat has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, A; Komune, S; Kuratomi, Y; Masuda, M; Nakagawa, T; Nakashima, T; Yasumatsu, R	1

Other Studies

1 other study(ies) available for perindoprilat and Head and Neck Neoplasms

Article	Year
Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line, Tumor; Female; Head and Neck Neoplasms; Immunoenzyme Techniques; Immunohistochemistry; Indoles; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Perindopril; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A	2004

Article

Year

Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells.

Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:10

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line, Tumor; Female; Head and Neck Neoplasms; Immunoenzyme Techniques; Immunohistochemistry; Indoles; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Perindopril; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A

2004